Evidence map›Paper›PMID 22530068›Full record

ArticlePloS one2012

Allergen micro-bead array for IgE detection: a feasibility study using allergenic molecules tested on a flexible multiplex flow cytometric immunoassay.

Debora Pomponi, Maria Livia Bernardi, Marina Liso, Paola Palazzo, Lisa Tuppo, Chiara Rafaiani, Mario Santoro, Alexis Labrada, Maria Antonietta Ciardiello, Adriano Mari and 1 more

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Diagnostic applications of microsphere-based flow cytometry: A review.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  5. The use of microarray and other multiplex technologies in the diagnosis of allergy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Review
  6. Article
  7. Microarray-Based Allergy Diagnosis: Quo Vadis?Frontiers in immunology · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Nanotechnologies for In Vitro IgE Testing.Current allergy and asthma reports · 2017
    Review
  12. Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.International archives of allergy and immunology · 2017
    Review
  13. How relevant is panallergen sensitization in the development of allergies?Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2016
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Molecular biomarkers for grass pollen immunotherapy.World journal of methodology · 2014
    Review
  19. Article
  20. Molecular approaches to allergen standardization.Current allergy and asthma reports · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Debora PomponiCenter for Molecular Allergology, IDI-IRCCS, Rome, Italy.
Maria Livia Bernardi
Marina Liso
Paola Palazzo
Lisa Tuppo
Chiara Rafaiani
Mario Santoro
Alexis Labrada
Maria Antonietta Ciardiello
Adriano Mari
Enrico Scala

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAllergies represent the most prevalent non infective diseases worldwide. Approaching IgE-mediated sensitizations improved much by adopting allergenic molecules instead of extracts, and by using the micro-technology for multiplex testing. OBJECTIVE AND

methodsTo provide a proof-of-concept that a flow cytometric bead array is a feasible mean for the detection of specific IgE reactivity to allergenic molecules in a multiplex-like way. A flow cytometry Allergenic Molecule-based micro-bead Array system (ABA) was set by coupling allergenic molecules with commercially available micro-beads. Allergen specific polyclonal and monoclonal antibodies, as well as samples from 167 allergic patients, characterized by means of the ISAC microarray system, were used as means to show the feasibility of the ABA. Three hundred and thirty-six sera were tested for 1 or more of the 16 selected allergens, for a total number of 1,519 tests on each of the two systems.

resultsSuccessful coupling was initially verified by detecting the binding of rabbit polyclonal IgG, mouse monoclonal, and pooled human IgE toward three allergens, namely nDer s 1, nPen m 1, and nPru p 3. The ABA assay showed to detect IgE to nAct d 1, nAct d 11, rAln g 1, nAmb a 1, nArt v 3, rBet v 1, rCor a 1, nCup a 1, nDer p 1, nDer s 1, rHev b 5, nOle e 1, rPar j 2, nPen m 1, rPhl p 1, and nPru p 3. Results obtained by ABA IgE testing were highly correlated to ISAC testing (r = 0.87, p<0.0001). No unspecific binding was recorded because of high total IgE values.

conclusionThe ABA assay represents a useful and flexible method for multiplex IgE detection using allergenic molecules. As also shown by our initial experiments with monoclonals and polyclonals, ABA is suitable for detecting other human and non-human immunoglobulins.

Indexed as

Microarray AnalysisAdolescentAdultAgedAged, 80 and overAllergensAntibodiesChildChild, PreschoolFeasibility StudiesFemaleFlow CytometryHumansHypersensitivityHypersensitivity, ImmediateImmunoassayAllergensAntibodiesImmunoconjugatesImmunoglobulin E

Identifiers

PMID22530068
PMCPMC3328437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.